Generics - Boardroom, Financial

Filter

Current filters:

BoardroomFinancial

Popular Filters

1 to 25 of 2568 results

Celgene beats expectations, despite profit downturn

24-04-2014

US biotech firm Celgene saw its shares fall 3.3% to $140.05 in mid-morning trading after it posted first-quarter…

BiotechnologyCelgeneFinancial

WuXi PharmaTech announces Management Appointments

WuXi PharmaTech announces Management Appointments

24-04-2014

China’s WuXi PharmaTech (NYSE: WX) has announced that Dr Steve Yang has joined the company as Executive…

BiotechnologyBoardroomChinaPharmaceuticalWuXi PharmaTech

AstraZeneca first quarter sales flat, but beat forecasts

24-04-2014

Anglo-Swedish drug major AstraZeneca this morning posted first-quarter 2014 financials, revealed sales…

AstraZenecaFinancialPharmaceutical

Eli Lilly 1st-qtr 2014 net income plunges, sales down, hit by generic competition

24-04-2014

US pharma major Eli Lilly posted first-quarter 2014 financial results, with revenue declined 16 % to…

Eli LillyFinancialPharmaceutical

Impax Laboratories appoints Frederick Wilkinson as President and CEO

Impax Laboratories appoints Frederick Wilkinson as President and CEO

24-04-2014

US generic drugmaker Impax Laboratories (NASDAQ: IPXL) has announced the appointment of Frederick Wilkinson…

BiotechnologyBoardroomImpax LaboratoriesPharmaceuticalUSA

Novartis 1st-qtr net profit flat, sales shy of forecasts

Novartis 1st-qtr net profit flat, sales shy of forecasts

24-04-2014

Swiss drug major Novartis posted a solid set of first-quarter 2014 financials this morning, showing that…

AlconFinancialNovartisPharmaceuticalSandoz

Biogen Idec 1st-qtr 2014 revenue leaps 51%, driven by Tecfidera and MS franchise

23-04-2014

US biotech firm Biogen Idec first-quarter 2014 results today, including revenue of $2.1 billion, a 51%…

Biogen IdecBiotechnologyFinancialNeurologicalResearchTecfidera

Abbott may acquire one of Russia’s leading drugmakers for $240 million

23-04-2014

The USA’s Abbott Laboratories is considering acquiring the 81.1 % stake in Veropharm, one of Russia’s…

Abbott LaboratoriesGenericsMergers & AcquisitionsRussiaVeropharm

Allergan adopts stockholder rights plan

23-04-2014

USA-based Allergan, the subject of a hostile takeover bid from Canada’s Valeant Pharmaceuticals reported…

AllerganFinancialMergers & AcquisitionsPharmaceuticalValeant Pharmaceuticals

Amgen's 1st-qtr 2014 disappoints, as net income falls 25%

23-04-2014

Amgen, the world’s largest independent biotech firm by revenues, yesterday announced financial results…

AmgenBiotechnologyFinancialResearch

Daiichi Sankyo names Ken Keller as President, US Commercial

Daiichi Sankyo names Ken Keller as President, US Commercial

23-04-2014

Japanese drugmaker Daiichi Sankyo has announced that Ken Keller will join the company as President of…

AmgenBoardroomBusiness FinanceDaiichi SankyoHealth Medical PharmaJapanKen KellerPharmaceuticalPharmaceutical experienceUSA

Lupin appoints Theresa Stevens as Chief Corporate Development Officer

Lupin appoints Theresa Stevens as Chief Corporate Development Officer

23-04-2014

Pharma major Lupin has announced the appointment of Theresa Stevens as Chief Corporate Development Officer…

BoardroomLupinPharmaceuticalUSA

Gilead 1st-qtr 2014 sales nearly double, fuelled by Sovaldi, as net income rockets

23-04-2014

US antivirals major Gilead Sciences posted first-quarter 2014 results after markets closed yesterday,…

Anti-viralsBiotechnologyFinancialGilead SciencesSovaldi

AbbVie files NDA for oral, interferon-free treatment of hepatitis C

22-04-2014

US drugmaker AbbVie has submitted its New Drug Application to the US Food and Drug Administration for…

AbbVieAnti-viralsEnanta PharmaceuticalsFinancialNorth AmericaPharmaceuticalRegulationUSA

Epizyme earns $4 million milestone under GSK collaboration

22-04-2014

US clinical-stage biopharma firm Epizyme announced the achievement of the lead candidate milestone for…

BiotechnologyEpizymeFinancialGlaxoSmithKlineLicensingOncology

AusBiotech to submit to Senate’s Australian innovation system inquiry

22-04-2014

Trade group AusBiotech is preparing a submission, following the Senate's referral of an inquiry into…

Asia-PacificAustraliaBiotechnologyFinancialResearch

Greek health system victim of debt crisis but reform now possible, say experts

22-04-2014

Greece's health care system was among the victims of the debt crisis which began four years ago, according…

EuropeFinancialGreeceHealthcarePharmaceuticalPolitics

Novartis appoints Jeff George as Division Head, Alcon and Richard Francis as Division Head, Sandoz

Novartis appoints Jeff George as Division Head, Alcon and Richard Francis as Division Head, Sandoz

22-04-2014

Swiss drug major Novartis has announced the appointment of Jeff George as Division Head of Alcon and…

AlconBoardroomNorthern EuropeNovartisPharmaceuticalSandoz

e-Therapeutics announces appointment of Steve Medlicott as Finance Director

e-Therapeutics announces appointment of Steve Medlicott as Finance Director

22-04-2014

UK-based drug discovery and development company e-Therapeutics has announced the appointment of Steve…

BoardroomManagementPharmaceutical

Adcock Ingram appoints CEO

Adcock Ingram appoints CEO

22-04-2014

South African drugmaker Adcock Ingram has announced the appointment of Kevin Wakeford (pictured) as Chief…

Adcock IngramBoardroomPharmaceuticalSouth Africa

NHS England agrees funding for Gilead’s hepatitis C drug Sovaldi

18-04-2014

NHS England has approved an £18.7 million ($31.3 million) investment in a new drug for the treatment…

Anti-viralsBiotechnologyFinancialGilead SciencesHealthcareNorthern EuropeSovaldiUK

Jacques Servier, founder and president of Lab Servier, dies aged 92

17-04-2014

French independent drugmaker Laboratories Servier announced that its founder and president, Jacques Servier,…

BoardroomManagementPharmaceuticalServier

Teva and Pfizer settle patent litigation over Celebrex

17-04-2014

Israel-based Teva Pharmaceutical Industries says that its US subsidiary has settled a law suit with US…

Anti-Arthritics/RheumaticsCelebrexGenericsNorth AmericaPatentsPfizerTeva Pharmaceutical IndustriesUSA

1 to 25 of 2568 results

Back to top